Cytokine Therapy in Rheumatoid Arthritis

Overview

Journal Springer Semin Immunopathol

Specialty Allergy & Immunology

Date 1998 Dec 4

PMID 9836382

Citations 2

Authors

J Hermann

M Walmsley

F M Brennan

Affiliations

Soon will be listed here.

Citing Articles

Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.

Fujikawa K, Aratake K, Kawakami A, Aramaki T, Iwanaga N, Izumi Y Ann Rheum Dis. 2006; 66(1):136-7.

PMID: 17178762 PMC: 1798413. DOI: 10.1136/ard.2006.056804.

Update on synovitis.

Szekanecz Z, Koch A Curr Rheumatol Rep. 2001; 3(1):53-63.

PMID: 11177771 DOI: 10.1007/s11926-001-0051-0.

References

Lacraz S, Nicod L, Baumberger C, Dayer J, Welgus H . Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest. 1992; 90(2):382-8. PMC: 443112. DOI: 10.1172/JCI115872. View

Wahl S, Hunt D, Wakefield L, McCartney-Francis N, Wahl L, Roberts A . Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987; 84(16):5788-92. PMC: 298948. DOI: 10.1073/pnas.84.16.5788. View

Fluckiger A, Durand I, Banchereau J . Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med. 1994; 179(1):91-9. PMC: 2191337. DOI: 10.1084/jem.179.1.91. View

Persson S, Mikulowska A, Narula S, OGarra A, Holmdahl R . Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol. 1996; 44(6):607-14. DOI: 10.1046/j.1365-3083.1996.d01-355.x. View

Fava R, Olsen N, Postlethwaite A, Broadley K, Davidson J, Nanney L . Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med. 1991; 173(5):1121-32. PMC: 2118851. DOI: 10.1084/jem.173.5.1121. View

OGarra A, Stapleton G, Dhar V, Pearce M, Schumacher J, Rugo H . Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol. 1990; 2(9):821-32. DOI: 10.1093/intimm/2.9.821. View

Dayer J, Beutler B, Cerami A . Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med. 1985; 162(6):2163-8. PMC: 2187983. DOI: 10.1084/jem.162.6.2163. View

Wahl S, Wilder R, Katona I, Wahl L, Allen J, SCHER I . Leukapheresis in rheumatoid arthritis. Association of clinical improvement with reversal of anergy. Arthritis Rheum. 1983; 26(9):1076-84. DOI: 10.1002/art.1780260904. View

Chomarat P, Vannier E, Dechanet J, Rissoan M, Banchereau J, Dinarello C . Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol. 1995; 154(3):1432-9. View

10.

Janossy G, Panayi G, Duke O, Bofill M, Poulter L, Goldstein G . Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet. 1981; 2(8251):839-42. DOI: 10.1016/s0140-6736(81)91107-7. View

11.

Miltenburg A, van Laar J, de Kuiper R, Daha M, Breedveld F . T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol. 1992; 35(5):603-10. DOI: 10.1111/j.1365-3083.1992.tb03260.x. View

12.

Fiorentino D, Bond M, Mosmann T . Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989; 170(6):2081-95. PMC: 2189521. DOI: 10.1084/jem.170.6.2081. View

13.

Moore K, OGarra A, de Waal Malefyt R, Vieira P, Mosmann T . Interleukin-10. Annu Rev Immunol. 1993; 11:165-90. DOI: 10.1146/annurev.iy.11.040193.001121. View

14.

Brennan F, Browne K, Green P, Jaspar J, Maini R, Feldmann M . Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy. Br J Rheumatol. 1997; 36(6):643-50. DOI: 10.1093/rheumatology/36.6.643. View

15.

Chang C, Furue M, Tamaki K . B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur J Immunol. 1995; 25(2):394-8. DOI: 10.1002/eji.1830250213. View

16.

Joyce D, Gibbons D, Green P, Steer J, Feldmann M, Brennan F . Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol. 1994; 24(11):2699-705. DOI: 10.1002/eji.1830241119. View

17.

Fava R, Olsen N, Keski-Oja J, MOSES H, Pincus T . Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med. 1989; 169(1):291-6. PMC: 2189180. DOI: 10.1084/jem.169.1.291. View

18.

Baumann H, Wang Y, Morella K, Lai C, DAMS H, Hilton D . Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J Immunol. 1996; 157(1):284-90. View

19.

Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O . Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem. 1994; 269(9):6271-4. View

20.

Te Velde A, Huijbens R, Heije K, De Vries J, Figdor C . Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood. 1990; 76(7):1392-7. View